Launch week offerEnds in00h00m00s

Justin M O’Sullivan

Has grant

Director

University of Auckland
Country flagNew Zealand

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Exploring the pervasive role of the GBA gene in development of Parkinson's disease

Open Date: 2021-01-01

Close Date: 2024-01-01

Grant: Close

Phages as modulators of the human gut microbiome

Open Date: 2020-01-01

Close Date: 2023-01-01

Grant: Close

Becoming master of your destiny: insights into genome activation from nuclear structure

Open Date: 2017-01-01

Close Date: 2020-01-01

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Chronic obstructive pulmonary disease (COPD) is a heterogeneous group of chronic lung conditions. Genome-wide association studies have identified single-nucleotide polymorphisms (SNPs) associated with COPD and the co-occurring conditions, suggesting common biological mechanisms underlying COPD and these co-occurring conditions. To identify them, we have integrated information across different biological levels (i.e., genetic variants, lung-specific 3D genome structure, gene expression and protein–protein interactions) to build lung-specific gene regulatory and protein–protein interaction networks. We have queried these networks using disease-associated SNPs for COPD, unipolar depression and coronary artery disease. COPD-associated SNPs can control genes involved in the regulation of lung or pulmonary function, asthma, brain region volumes, cortical surface area, depressed affect, neuroticism, Parkinson’s disease, white matter microstructure and smoking behaviour. We describe the regulatory connections, genes and biochemical pathways that underlay these co-occurring trait-SNP-gene associations. Collectively, our findings provide new avenues for the investigation of the underlying biology and diverse clinical presentations of COPD. In so doing, we identify a collection of genetic variants and genes that may aid COPD patient stratification and treatment.

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Gustavo de los Campos

Michigan State University

UNITED STATES
View details

Ana I Vazquez

Michigan State University

UNITED STATES
View details

Jessica A. Kerr

Senior Research Fellow

University of Otago Christchurch

NEW ZEALAND
View details

Tony Merriman

Research Professor

University of Otago

NEW ZEALAND
View details

Tayaza Fadason

University of Auckland

NEW ZEALAND
View details

Sophie Farrow

Parkinson's UK Senior Research Fellow

University of Oxford

UNITED KINGDOM
View details

Antony Cooper

Research Director

Garvan Institute of Medical Research

AUSTRALIA
View details

Susan Clifford

Murdoch Childrens Research Institute

AUSTRALIA
View details

William Schierding

Senior Research Fellow

University of Auckland

NEW ZEALAND
View details

Chris Pook

University of Auckland

NEW ZEALAND
View details